Register / Log In

Topic-Based
Resource Centers

Melanoma: Advances in Diagnosis & Therapy

TAGS   DermatologyMelanomaMetastatic MelanomaSkin CancerOncologySkin Exam

RELATED ARTICLES

 
ABCDEs of melanoma not applicable to all patients

New ABCDEs of melanoma not applicable to all patients

 

Many pediatric patients with melanoma do not demonstrate symptoms falling within the ABCDE detection criteria, researchers say.

More...

 
 
Genetic test predicts melanoma recurrence risk

New Genetic test predicts melanoma recurrence risk

 

A new genetic test can identify patients with nonmetastatic melanoma who are at high risk of recurrence, according to validation data presented at the 2013 summer meeting of the American Academy of Dermatology.

More...

 
 
Targeted therapy, immunotherapy tackle metastatic melanoma

Targeted therapy, immunotherapy tackle metastatic melanoma

 

There has been a rapid revolution in the treatment of metastatic melanoma since the identification of driver oncogenes such as BRAF and its mutations more than a decade ago.

More...

 
 
Trial Shows Benefits to Immediate Lymph Node Dissection in Some Melanoma Cases

Trial Shows Benefits to Immediate Lymph Node Dissection in Some Melanoma Cases

 

Positive SLNB patients with intermediate thickness melanoma and metastatic disease to regional nodes may have a survival benefit if they receive immediate lymph node dissection. This approach may be preferable when disease in regional nodes becomes clinically palpable, says John F. Thompson M.D., professor of surgery, University of Sydney, and executive director of the Melanoma Institute Australia, Sydney.

More...

 
 
Sentinel Lymph Node Biopsy Appropriate for Certain Thin Melanomas

Sentinel Lymph Node Biopsy Appropriate for Certain Thin Melanomas

 

Sentinel lymph node (SLN) status represents the most important prognostic factor for disease-specific survival in primary cutaneous melanomas, said Christopher K. Bichakjian, M.D., associate professor, cutaneous surgery and oncology, University of Michigan, Ann Arbor.

More...

 
 
Novel Melanoma Therapies Portend a 'Golden Age' of Cancer Care

Novel Melanoma Therapies Portend a 'Golden Age' of Cancer Care

 

Newly approved drugs such as vemurafenib and ipilimumab are creating a "game-changing" era for treatment of metastatic melanoma, according to Adil Daud, M.D., co-director, Melanoma Program, University of California, San Francisco.

More...

 
 
Radiotherapy Boosts Efficacy of Ipilimumab in Metastatic Melanoma

Radiotherapy Boosts Efficacy of Ipilimumab in Metastatic Melanoma

 

As researchers continue to study the effects of adjunctive therapies with ipilimumab, a recent report suggests radiotherapy may increase its efficacy, according to Michael A. Postow, M.D., medical oncology fellow, Memorial Sloan-Kettering Cancer Center, New York.

More...

 
 

CME

 

Melanoma: Update on Emerging Therapies 1

Release date: May 8, 2012
Expiration date: May 8, 2013

 

Learning Objectives:

  • Evaluate the role of adjuvant interferon-? therapy in patients with melanoma
  • Discuss the potential prognostic markers for response to adjuvant interferon-? therapy in patients with melanoma
  • Identify patients who may benefit from BRAF inhibitor therapy

 

View Activity

 

TOOLS

 
Dermatology Diagnosis Counselor

DERMATOLOGY
DIAGNOSIS COUNSELOR

VisualDx